{"id":70421,"date":"2023-04-22T00:46:01","date_gmt":"2023-04-21T22:46:01","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?page_id=70421"},"modified":"2026-05-20T14:54:03","modified_gmt":"2026-05-20T12:54:03","slug":"cour-pharma-the-race-to-high-value-engagement","status":"publish","type":"customer-stories","link":"https:\/\/www.veeva.com\/eu\/customer-stories\/cour-pharma-the-race-to-high-value-engagement\/","title":{"rendered":"COUR Pharma"},"content":{"rendered":"

Malcolm Crooks, COO of COUR Pharmaceuticals, discusses how to accelerate the shift to high-value engagement.<\/p>\n

Learn how the industry is achieving commercial excellence<\/a> in sales, medical, and marketing.<\/p>\n","protected":false},"excerpt":{"rendered":"

COUR Pharmaceuticals, discusses how to accelerate the shift to high-value engagement.<\/p>\n","protected":false},"featured_media":69872,"parent":0,"template":"","product-link-list":[],"class_list":["post-70421","customer-stories","type-customer-stories","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/70421"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/customer-stories"}],"version-history":[{"count":4,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/70421\/revisions"}],"predecessor-version":[{"id":70809,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/70421\/revisions\/70809"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/69872"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=70421"}],"wp:term":[{"taxonomy":"product-link-list","embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/product-link-list?post=70421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}